[go: up one dir, main page]

KR20020037241A - Synthesis and characterization of new chitosan derivatives by use of amino acid - Google Patents

Synthesis and characterization of new chitosan derivatives by use of amino acid Download PDF

Info

Publication number
KR20020037241A
KR20020037241A KR1020000068252A KR20000068252A KR20020037241A KR 20020037241 A KR20020037241 A KR 20020037241A KR 1020000068252 A KR1020000068252 A KR 1020000068252A KR 20000068252 A KR20000068252 A KR 20000068252A KR 20020037241 A KR20020037241 A KR 20020037241A
Authority
KR
South Korea
Prior art keywords
acid
chitosan
amino
compound
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020000068252A
Other languages
Korean (ko)
Inventor
류성렬
Original Assignee
류 성 렬
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 류 성 렬 filed Critical 류 성 렬
Priority to KR1020000068252A priority Critical patent/KR20020037241A/en
Publication of KR20020037241A publication Critical patent/KR20020037241A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 키토산 유도체로서 식용으로 유용한 하기 화학식 (I)로 표시되는 키토산을 이용한 천연 고분자 항균아미노산 그의 제조 방법 및 이들의 응용방법 등으로서의 효능 및 용도에 관한 것이다.The present invention relates to a method for producing a natural polymer antimicrobial amino acid using chitosan represented by the following general formula (I), which is useful for food, as a chitosan derivative, and to its efficacy and use as an application method thereof.

Description

아미노산을 이용한 새로운 키토산 유도체의 합성 및 특성{Synthesis and characterization of new chitosan derivatives by use of amino acid}Synthesis and characterization of new chitosan derivatives by use of amino acid}

본 발명은 현재 쓰이고 있는 천연 항균제인 키토산 유도체로서 하기 구조식[Ⅰ]의 신규한 키토산 유도체 및 그의 제조방법에관한 것이다.The present invention relates to a novel chitosan derivative of the following structural formula [I] as a chitosan derivative which is a natural antimicrobial agent currently used, and a method for producing the same.

상기식에서 구조식[I], [II]의 화합물은 키토산에 아미노산 및 유기산이 결합된 구조를 갖는다. 최근 의약 및 식품분야에서 신물질 창출은 우리나라가 당면하고 있는 과학기술 분야의 문제중에서 가장 시급하게 해결해야할 과제중의 하나라고 할 수 있다. 한편 최근 식품등에 과다한 농약 첨가로 인한 잔류농약 문제가 인체에 미치는 영향은 날로 심각한 상태이며, 최근 메스컴 보도에서도 심각성을 보도한 바와 같이 농약 사용이 사용 기준치의 한계를 크게 웃도는등 이로인한 식품 섭취에 따를 건강 피해는 성인은 물론 2차 감염등으로 신생아에서 부터 태아에 이르기 까지 건강에 큰 위협이되고 있다. 그러나 아직까지도 항산화제제들과 과다한 농약이 사용되고 있으며 또한 포르말린 살포등으로 여러가지 잔류농약제가 건강에 큰 위협이되고 있다. 그러한 가운데 최근 천연물 소제인 키틴 키토산의 항균 및 항진균 효능을 이용하는 다각적인 연구가 활발히 이루어지고 있다 할 수 있다.In the above formula, the compounds of structural formulas [I] and [II] have a structure in which amino acids and organic acids are bonded to chitosan. In recent years, the creation of new materials in medicine and food is one of the most urgent tasks to be solved among the problems of science and technology. Meanwhile, the effects of pesticide residue on the human body due to excessive addition of pesticides to foods are serious, and as reported recently in the media, the use of pesticides greatly exceeds the limit of the standard of use. Health damage is a serious threat to health from newborns to fetuses as well as secondary infections as well as adults. However, antioxidants and excessive pesticides are still used, and various residual pesticides are a major threat to health due to formalin spraying. In the meantime, various studies using the antibacterial and antifungal efficacy of chitin chitosan, a natural product, have been actively conducted.

특히 키토산은 새우, 게 등의 갑각류와 곤충, 버섯, 세균의 세포벽 등에 광범위하게 존재하고 있는 물질로 지구상에 셀루로스 다음으로 많은 양이 생성되고 있는 바이오 메스물질이다. 이 키토산은 식물계의 셀루로스와 같이 생물체의 외골격을 형성하여 지지나 방호 역할을 담당하는 물질이 키틴질을 가수분해하여 얻어지며 키틴질은 아미노기가 아세틸化된 N-아세틸-D-그루코사민이β-1, 4 결합된 고분자 다당체로서 존재한다. 먼저, NaOH나 KOH를 이용 탈단백질을 한후 5%의 HCl용액에서 칼슘을 포함한 무기물질을 제거하면 불용성 물질이 남게 되는데 이것이 키틴이다. 이 키틴을 진한 알카리 수용액에서 열을 가하면서 가수분해 시킨 물질이 키토산이다. 이렇게 가수분해 시킬 때 탈아세틸化 시키는 정도에 따라 본 연구팀이 개발 하고자 하는 chitosan 유도체는 또 생리활성 증대물질로서 유사한 약제들은 유일하게 chitosan 자체가 갖는 아미노기 양전하의 특성 효과로 항균력이 천연물 자체로서도 우수하다. 그래서 이를 응용하여 특이한 화학구조를 이루고 있으나 항균성에 탁월한 활성 효염이 있는 NH2-Chitosan 유도체를 합성하기 위하여 일부 보고된 일반적인 키토산 항균제 유도체인 연구 학술적 자료 보고에 국한된 틀을 벗어나 실용화될수 있는 순수 천연물질 소재로 합성을 시도하고 또한 천연 아미노산을 이용하여 이를 화학적인 방법으로 커풀링을 시도하려고 한다. 그래서 이지역 특산물로 대량 활용 가능한 천연물질인 천연소재 또는 아미노산류 및 생리 활성물질을 이용하여 키토산과 새로운 화합물을 합성하여 보다 항균활성이 증가된 새로운 리드 화합물로의 식품첨가제인 항균제를 개발하고자 하였다. 그래서 과일로부터 화학결합적 가교 가능성 있는 항균성 항균활성 물질 분리 와 천연 생고분자인 키토산 및 키틴을 이용한 활성물질과의 합성 그리고 Amino acid 와 키토산 및 키틴과의 유도체 합성하여 이에대한 전 임상실험을 통하여 최종 후보물질을 확정 하고 신규성으로 키토산이 물에 안녹는것에 비해서 물에 잘 녹는특이성이 발견되어 출원하고자 합니다.In particular, chitosan is a substance that is present in a wide range of shells such as shrimp and crabs, and the cell walls of insects, mushrooms, and bacteria. This chitosan is obtained by hydrolyzing chitin by a substance that forms an exoskeleton of an organism like cellulose of a plant, and supports or protects the chitin, and β- 1 by N-acetyl-D-glucosamine where the amino group is acetylated. , 4-linked polymer polysaccharides. First, demineralization using NaOH or KOH and then removing calcium-containing inorganic substances from 5% HCl solution leaves insoluble substances. This is chitin. Chitosan is a substance that hydrolyzes chitin in concentrated alkaline aqueous solution. According to the degree of deacetylation during hydrolysis, the chitosan derivatives that the team intends to develop are also biologically active substances, and similar drugs are the only ones that have superior antimicrobial activity as natural products due to the characteristic effect of the positive charge of amino groups in chitosan itself. Therefore, it is a pure natural material that can be put to practical use beyond the scope of the research academic data, which is a common chitosan antimicrobial derivative reported in order to synthesize NH 2 -Chitosan derivative which has a specific chemical structure but has an active effect excellent in antimicrobial activity. In addition, it attempts to synthesize by using a natural amino acid and to try to couple it by chemical method. Therefore, by using chitosan and new compounds by using natural materials or amino acids and physiologically active substances, which are mass materials that can be used as a special product of this region, we tried to develop an antimicrobial agent as a food additive as a new lead compound with increased antibacterial activity. Therefore, the final candidates were obtained through the preclinical experiments on the separation of antimicrobial antimicrobial active substance with chemically crosslinking potential from fruit, the synthesis of active substance using natural chitosan and chitin, and the synthesis of Amino acid and chitosan and chitin. We have decided to apply for the discovery of a substance and the uniqueness of water dissolving in chitosan.

..

제 1도는 아미노산을 이용한 키토산과의 결합방법을 나타냄1 shows a method of binding to chitosan using amino acids

제 2도는 아세틸기 함유에 따른 유기산을 이용한 키토산과의 결합방법을 나타냄2 shows a method of binding to chitosan using an organic acid containing acetyl group.

제 3도는 유기산을 이용한 키토산과의 결합방법을 나타냄3 shows a method of binding to chitosan using an organic acid.

실시예 1Example 1

2. 재료 및 방법(연구방법)2. Materials and Methods (Research Methods)

2-1. 재료2-1. material

2-1-1. 본 실험에 사용한 키틴은 전남 목포시 소재 바이오테크(사)에서 붉은 대게(Chinoecetes japonicus) 각질로 부터 추출한 것으로 일정한 크기로 마쇄(50mesh)하여 0-5℃의 냉장고에 보관하여 두고 실험에 사용하였다.2-1-1. The chitin used in this experiment was extracted from keratin (Chinoecetes japonicus) keratin from Biotech Co., Ltd., Mokpo-si, Jeonnam, and ground to a constant size (50mesh) and stored in a refrigerator at 0-5 ℃ for use in the experiment.

2-1-2. 합성한 Benzimidazole치환 키토산 유도체 화합물에 대한 Minimum Inhibitory Concentration(MICin vitro)의 측정2-1-2. Measurement of Minimum Inhibitory Concentration (MIC in vitro ) on Synthesized Benzimidazole-Substituted Chitosan Derivatives

2-1-2-1.사용균주2-1-2-1.Use strain

본 실험에 사용한 미생물은Escherichia coli0157:H7 균과 진균으로Candida utilis,Candida albicansATCC 10231,Saccharomyces cerevisiaeATCC9763 ,Aspergillus niger9029 을 사용하였다.The microorganisms used in this experiment were Escherichia coli 0157: H7 and fungi Candida utilis , Candida albicans ATCC 10231, Saccharomyces cerevisiae ATCC9763 and Aspergillus niger 9029.

2-1-2-2. 사용배지2-1-2-2. Used badge

본 실험에 사용한 세균용 배지: Mueller Hinton broth, Mueller Hinton ager이며 진균용 배지: Sabouraud Dextrose Broth, Sabouraud Dextrose agar로 조정하여 사용하였다.Bacterial media used in this experiment: Mueller Hinton broth, Mueller Hinton ager and fungal media: Sabouraud Dextrose Broth, Sabouraud Dextrose agar.

2-1-2-3. 시약 및 사용기기2-1-2-3. Reagents and Equipment

시약 및 용매는 Aldrich사 제품을 그대로 사용하였고, 분리한 화합물을 확인하는데 사용한 기기중 융점 측정은 Thomas Hoover melting point Apparatus를 사용하였으며 보정은 하지 않았다. 핵자기공명 분광기는 Varain T60과 HA-100을 사용하였다. 적외선 분광기는 Bio-Red FTS-45A Spectrophotometer를 사용하여 얻었다. T.L.C plate는 Merck DC-plastik follen Kieselgsl 60F 254를 사용하고, 키토산은 탈아세틸화도가 89%, 점도 20cps이며, Bacillus pumilus BM- 유래 chitosanase (분자량: 약 30,000 Da, 최저 pH: 5.5∼605, 최적온도: 30∼50℃, 등전점: 약 93)은 Wakopure Chemical사 (대, 日本)에서 구입하였으며, D-글루코사민은 Sigma Chemical사 (St. Louis, USA)에서 구입하였다. 키토산 유도체 합성을 위한 아미노산인 Gly, Ala, Asp Asn, Boc-S-(p-methoxybenzyl)-L-Cys 및 Boc-L-Met와 합성 촉매제인 DCC (N,N'-dicyclohexyl-carbodiimide)는 Sigma Chemical사로부터 구입하여 사용하였다.Reagents and solvents were used as Aldrich Co., Ltd. The melting point of the instrument used to identify the separated compound was measured by Thomas Hoover melting point Apparatus was not calibrated. The nuclear magnetic resonance spectrometer used Varain T60 and HA-100. Infrared spectroscopy was obtained using a Bio-Red FTS-45A Spectrophotometer. TLC plate uses Merck DC-plastik follen Kieselgsl 60F 254, chitosan has 89% deacetylation, viscosity 20cps, chitosanase derived from Bacillus pumilus BM- (molecular weight: about 30,000 Da, minimum pH: 5.5 ~ 605, optimum temperature) : 30 to 50 ° C., isoelectric point: about 93) was purchased from Wakopure Chemical Co., Ltd., Japan, and D-glucosamine was purchased from Sigma Chemical Co., Ltd. (St. Louis, USA). The amino acids Gly, Ala, Asp Asn, Boc-S- (p-methoxybenzyl) -L-Cys and Boc-L-Met for synthesis of chitosan derivatives and DCC (N, N'-dicyclohexyl-carbodiimide) as a synthesis catalyst are Sigma It was purchased from Chemical Company.

2-2. 방법2-2. Way

2-2-1. 메탄올 추출물 조제와 검정 배지 제조 및 항미생물 활성 측정:2-2-1. Preparation of methanol extract and assay medium and determination of antimicrobial activity:

1). 균희석액을 만들기 위해 전배양은 균의 농도가 104-106CFU/ml가 되게 희섞한다.One). To make the fungal diluent, preculture is mixed with a concentration of 10 4 -10 6 CFU / ml.

2). 각 검체를 알맞은 용매로 녹인 후 배지로 2배 희석법으로 희석한다.2). Each sample is dissolved in a suitable solvent and then diluted in 2-fold dilution with medium.

3). 각각의 시험관에 균액을 접종한다.3). Inoculate each test tube with bacterial solution.

4). 세균은 37도 24시간 배양하며 진균은 36-48 시간 배양한다.4). Bacteria are incubated at 37 degrees for 24 hours and fungi are incubated for 36-48 hours.

5). 각 배양이 끝난 후 시험관을 흔들어 균의 탁도를 확인한다.탁도 여부를 확인한 후 각각을 Mueller Hinton ager, Sabouraud Dextrose agar배지에 제 접종하여 확인한다.5). After each incubation, shake the test tube to check the turbidity of the bacteria. After checking the turbidity, check each of them by re-inoculating each of Mueller Hinton ager and Sabouraud Dextrose agar.

6). 균의 성장여부를 확인한 후 성장이 인정되지 않는 가장 낮은 농도의 시험관 농도를 정하여 상기와 같은 액체배지 희석법(Broth Serial Dilution Method)으로 MIC를 정한다.6). After confirming the growth of the bacteria, determine the lowest test tube concentration at which growth is not recognized and determine the MIC by the broth serial dilution method as described above.

2-2-2. 각 화합물에 대한 항균 활성효과:2-2-2. Antimicrobial activity against each compound:

합성 화합물과 대조 화합물로 chitosan에 대한 in vitro에서 최소발육 저지농도(MIC, (㎍/ml))에 대한 측정결과는 Table 1에 수록 하였다.Measurement results for the synthetic compound and control compound minimum inhibitory concentration in the i n vitro for the chitosan in (MIC, (㎍ / ml) ) was given in Table 1.

2-2-3. Chitosan의 제조2-2-3. Manufacture of Chitosan

붉은 대게 껍질로부터 키틴의 추출은 갑각류 껍질 중량에 대하여 35배의 4N HCl를 가하여 탈회분화 시킨 다음 1N NaOH 용액을 사용하여 1시간 반응시켜 탈 단백질화 하였다. 이후 0.5%의 과망간산 칼륨으로 탈색시킨 후 여과 및 수세공정을 거쳐 열풍건조기로 60℃에서 건조하여 키틴을 제조하였다Chitin was extracted from the red snow crab shells and demineralized by adding 35 times of 4N HCl to the crustacean shell weight, followed by 1 hour reaction with 1N NaOH solution for deproteinization. Then, decolorized with 0.5% potassium permanganate, filtered, washed with water, and dried at 60 ° C. using a hot air dryer to prepare chitin.

2-4. Acetyl화 측정2-4. Acetylation Measurement

본 연구에서 분리한 키틴, 키토산의 원소분석 결과와 완전한 키틴 키토산 원소분석 결과와의 질량% 결과로부터 N/C에 따른 계산값으로 환산하여 비교하였다.In this study, the mass% results of the chitin and chitosan elemental analysis and the chitin chitosan elemental analysis were compared and calculated in terms of N / C.

실시예 2Example 2

2-5-1. Benzimidazole을 이용한 Benzimidazole유도체 합성2-5-1. Benzimidazole Derivative Synthesis Using Benzimidazole

1. 중간 유도체 화합물(3b) 합성1. Synthesis of Intermediate Derivative Compound (3b)

삼구 둥근 플라스크 50 ml에 화합물(2) 1.5 g을 녹이고 여기에 황산 13 ml와 질산 10 ml를 5℃이하에서 10분간 넣고 20분간 반응 시켰다. 그리고 혼합용액을 얼음물30 ml에 분산 시키고 방치한 다음 생성된 결정화합물1.8 g을 얻었다. 다시 이혼합물을 건조시킨 다음 칼럼 크로마토그래피를 이용하여 분리해서 2 위치에 치환된 노란색 결정화합물 0.7 g을 얻었다.1.5 g of Compound (2) was dissolved in 50 ml of a three-necked round flask, and 13 ml of sulfuric acid and 10 ml of nitric acid were added thereto for 10 minutes at 5 ° C. or lower and allowed to react for 20 minutes. The mixed solution was dispersed in 30 ml of iced water and left to obtain 1.8 g of the resulting crystal compound. The mixture was dried again and separated by column chromatography to obtain 0.7 g of a yellow crystalline compound substituted at the 2nd position.

실시예 3Example 3

2. 중간 유도체 화합물(4) 합성2. Synthesis of Intermediate Derivative Compound (4)

재 증류한 EtOH 30 ml에 화합물(3b) 10.5 g (0.06 mole)을 녹이고 Pd-C를 가하여 교반한 다음 수소가스를 통과시키면서 반응이 완료될때까지 환원반응을 진행하였다. 반응이 완료되면 혼합물을 걸르고 에탄올 10 ml로 다시 세척한 다음 여액을 모아 감압농축한 다음 생성된 결정화합물을 건조하여 7.72 g을 얻었다.10.5 g (0.06 mole) of Compound (3b) was dissolved in 30 ml of re-distilled EtOH, and stirred with Pd-C, followed by a reduction reaction until the reaction was completed while passing hydrogen gas. After the reaction was completed, the mixture was filtered, washed with 10 ml of ethanol again, and the filtrate was concentrated under reduced pressure, and the resulting crystal compound was dried to yield 7.72 g.

수율: 88.2%Yield: 88.2%

실시예 4Example 4

3. Benzimidazole유도체 합성3. Synthesis of Benzimidazole Derivative

100 ml 삼구풀라스크에 PPA 27 ml에 화합물(5) 1.5g (0.014 mole)을 녹이고이어서β-PA를 0.014 mole을 가하면서 90℃ 이상에서 6시간동안 반응시킨 다음 생성된 결정화합물을 모으고 이를 건조시킨 다음 에탄올 60 ml 로 재 결정하여 화합물(6)을 1.32 g을 얻었다.Dissolve 1.5 g (0.014 mole) of compound (5) in 27 ml of PPA in 100 ml three-necked pusque, then react β- PA with 0.014 mole for 6 hours at 90 ° C or more, collect the resulting crystals and dry it. After recrystallization with 60 ml of ethanol to give 1.32 g of compound (6).

실시예 5Example 5

4. Benzimidazole유도체를 이용한 키토산 유도체 합성(A)4.Synthesis of Chitosan Derivatives Using Benzimidazole Derivatives (A)

재 증류한 DMF 80 ml에 화합물 chitosan 5.5 g을 넣고 이어서 화합물(6)을 키토산기준 1/2 mole 넣은 다음 80℃ 이상에서 6시간동안 반응시킨 다음 생성된 결정화합물을 모으고 이를 증류수 50 ml, 에탄올 60 ml, ether 60 ml 순으로 씻어준 다음 키토산 유도체화합물(7)을 6.13 g 얻었다.5.5 g of the compound chitosan was added to 80 ml of re-distilled DMF, followed by adding 1/2 mole of the compound (6) to the chitosan standard and reacting at 80 ° C. or higher for 6 hours. The resultant crystals were collected and 50 ml of distilled water and 60 ethanol were added. After washing with 60 ml of ether and 6.13 g of chitosan derivatives (7) were obtained.

실시예 6Example 6

5. Benzimidazole유도체를 이용한 키토산 유도체 합성(B)5.Synthesis of Chitosan Derivatives Using Benzimidazole Derivatives (B)

빙초산 3%-EtOH 혼합용액 30 ml에 화합물 chitosan 1.5 g을 넣고 이어서 화합물(8)을 키토산기준 1/3 mole 넣은 후 10시간동안 교반한 다음 pH처리후 생성된 결정화합물을 모으고 이를 증류수 50 ml, 에탄올 60 ml, ether 60 ml 순으로 씻어준 다음 키토산 유도체화합물(7)을 1.2 g 얻었다.1.5 g of the compound chitosan was added to 30 ml of a mixture of glacial acetic acid 3% -EtOH, and then compound (8) was added to 1/3 mole of chitosan standard, stirred for 10 hours, and then the resulting crystal compound was collected and 50 ml of distilled water was collected. After washing with 60 ml of ethanol and 60 ml of ether, 1.2 g of chitosan derivative compound (7) was obtained.

실시예 7Example 7

6-2). 화합물에 대한 항균 활성효과:6-2). Antimicrobial Activity on Compounds:

합성 화합물과 대조 화합물로 chitosan에 대한 in vitro에서 최소발육 저지농도(MIC, (㎍/ml))에 대한 측정결과는 Table 1에 수록 하였다.Measurement results for the synthetic compound and control compound minimum inhibitory concentration in the i n vitro for the chitosan in (MIC, (㎍ / ml) ) was given in Table 1.

각 화합물에 대한 항 미생물의 활성관계:Activity of antimicrobial activity for each compound:

키토산 유도체을 pH 4.9-5.0 로 조절한 묽은 초산용액을 액체배지에서 배양하면서 최소저해농도를 측정한 결과는 표 1.과 같다.The results of measuring the minimum inhibitory concentrations while culturing the diluted acetic acid solution in which the chitosan derivative was adjusted to pH 4.9-5.0 in a liquid medium are shown in Table 1.

합성한 화합물(A)의 최소저해농도는Candida albicansATCC 10231,Candida utilis, Saccharomyces cerevisiaeATCC 9763,Aspergillus niger9029등 에서는 모두 300 ㎍/ ㎖,250㎍/ ㎖,600㎍/ ㎖,400㎍/ ㎖로 키토산에 비하여 비교적 낮은 농도에서 생육이 억제되었으나, 세균에서는 E.coli균주가 800㎍/ ㎖로 가장 높게 나타났다. 한편 화합물(B)는Candida albicansATCC 10231이 300 ㎍/ ㎖로 화합물(A)와 같게 나타났으나Candida utilis, Saccharomyces cerevisiaeATCC 9763,Aspergillus niger9029인 균류에는 화합물(A)에 비교했을 때 비교적 활성 이 낮았다. 그러나 이들 키토산 -벤지미다졸성 화합물들은 전반적으로 키토산 보다항진규 활성도가 7-10배정도 항균활성을 나타냈다.The minimum inhibitory concentration of the synthesized compound (A) was 300 ㎍ / ㎖, 250 ㎍ / ㎖, 600 ㎍ / ㎖, 400 ㎍ / ㎖ with Candida albicans ATCC 10231, Candida utilis, Saccharomyces cerevisiae ATCC 9763, Aspergillus niger 9029, etc. Growth was inhibited at a relatively low concentration compared to chitosan, but E. coli strain was the highest in bacteria at 800 µg / ml. Meanwhile, the compound (B) is relatively free of activity when it is compared with the compound (A) Candida albicans ATCC 10231 is shown the same as compound (A) to 300 ㎍ / ㎖ nateu or Candida utilis, Saccharomyces cerevisiae ATCC 9763, Aspergillus niger 9029 of the fungus Low. However, these chitosan-benzimidazole compounds showed antibacterial activity about 7-10 times higher than chitosan.

..

Claims (6)

하기 화학식[I], [II]의 화합물Compounds of the formula [I], [II] 상기식 중,In the above formula, 치환기는 알긴산,아미노산(아스파틱 에시드, 글루타믹 에시드, 기타 아미노 아세틱 에시드, 석신산 등)을 나타내고, n은 0 내지 10,000 이상의 중합도를 나타낸다. 또 아세틸화도는 20-100을 갖는다Substituents represent alginic acid, amino acids (aspartic acid, glutamic acid, other amino acetic acid, succinic acid, etc.), and n represents a degree of polymerization of 0 to 10,000 or more. The degree of acetylation also has 20-100 상기식에서 제시된 아미노산 결합방법에 따른 구성성분외 다른 아미노산을 결합하는 방법도 포함됨In addition to the components according to the amino acid binding method shown in the formula also includes a method for binding other amino acids 하기 화학식[I],[II]의 화합물을 용매 중에서 제 1항에 있어서, 키토산 화합물에 대해 아미노산 및 유기산 (예 숙신산 등)의 에스테르방법으로 에시드를 보호한다음 무수물로 제조하는 방법과 아미노산을 이용하여 개미산 및 초산을 혼합하여 아미노기를 포밀에이션 시키면서 동시에 무수물로제조하여 생성된 N-포밀 아미노산의 형태로 키토산과 결합하고 알킬 아미드를 이용하거나 수소화 반응을 이용하여 포밀기 및 벤질기를 제거하여 아미노산을 결합하는 방법The compound of formula [I], [II] according to claim 1, wherein the acid is protected by an ester method of an amino acid and an organic acid (e.g. succinic acid, etc.) with respect to the chitosan compound, and then prepared using an anhydride and an amino acid. The mixture of formic acid and acetic acid to form an amino group and at the same time to form an anhydride, combined with chitosan in the form of N-formyl amino acid produced by using an alkyl amide or a hydrogenation reaction to remove formyl and benzyl groups to combine amino acids How to 제3항에 있어서, 용매로서 메탄올, 에탄올, 아세토니트릴, 이소프로필 알콜 (IPA), 초산, 젖산, 염산(HCl)으로 이루어진 군 중에서 선택된 하나 이상의 용매를 사용하여 초산, 개미산을 사용하여 pH 3-5를 갖는 조성물 방법.According to claim 3, pH 3- using acetic acid, formic acid using at least one solvent selected from the group consisting of methanol, ethanol, acetonitrile, isopropyl alcohol (IPA), acetic acid, lactic acid, hydrochloric acid (HCl) as a solvent A composition method having five. 3항에 있어서, 반응을 25-90 ℃, pH = 5 - 7.5에서 수행하는 것인 방법으로 올리고당 및 키토산함유 항균 아미노산 및 유기산 제조방법The method for preparing oligosaccharide and chitosan-containing antibacterial amino acid and organic acid according to claim 3, wherein the reaction is carried out at 25-90 ° C., pH = 5-7.5. 제1항 내지 제3항 중 어느 한 항에 따른 항미생물제, 사료첨가제, 식료품 포장 코팅제, 식료품 가공첨가제, 과일 코팅제, 직물피복제 및 조성물, 식물 제배시 농약 대체물, 피부연고제, 화장퓨품 원료, 액체 샴푸,액체 비누 조성물, 피부질환 치료제로서의 용도The antimicrobial agent, feed additive, food packaging coating agent, food processing additive, fruit coating agent, textile coating and composition, pesticide substitute in plant breeding, skin ointment, cosmetic raw material, liquid according to any one of claims 1 to 3. Use as a shampoo, liquid soap composition, and skin disease treatment
KR1020000068252A 2000-11-12 2000-11-12 Synthesis and characterization of new chitosan derivatives by use of amino acid Ceased KR20020037241A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020000068252A KR20020037241A (en) 2000-11-12 2000-11-12 Synthesis and characterization of new chitosan derivatives by use of amino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000068252A KR20020037241A (en) 2000-11-12 2000-11-12 Synthesis and characterization of new chitosan derivatives by use of amino acid

Publications (1)

Publication Number Publication Date
KR20020037241A true KR20020037241A (en) 2002-05-18

Family

ID=19699536

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000068252A Ceased KR20020037241A (en) 2000-11-12 2000-11-12 Synthesis and characterization of new chitosan derivatives by use of amino acid

Country Status (1)

Country Link
KR (1) KR20020037241A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010106359A (en) * 2001-10-30 2001-11-29 조석형 Chelate compound for animals feed
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
CN105113053A (en) * 2015-08-27 2015-12-02 常州大学 Preparation method of hyaluronic acid derivative /chitosan derivative compound polyelectrolyte bi-crosslinking fiber

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010106359A (en) * 2001-10-30 2001-11-29 조석형 Chelate compound for animals feed
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US8658775B2 (en) 2006-06-02 2014-02-25 Shenda Baker Chitosan-derivative compounds and methods of controlling microbial populations
US9029351B2 (en) 2006-06-02 2015-05-12 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US9732164B2 (en) 2006-06-02 2017-08-15 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
CN105113053A (en) * 2015-08-27 2015-12-02 常州大学 Preparation method of hyaluronic acid derivative /chitosan derivative compound polyelectrolyte bi-crosslinking fiber

Similar Documents

Publication Publication Date Title
Savin et al. Antioxidant, cytotoxic and antimicrobial activity of chitosan preparations extracted from Ganoderma lucidum mushroom
Gomaa Microbial chitinases: properties, enhancement and potential applications
Tajdini et al. Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus
US7556946B2 (en) Cell wall derivatives from biomass and preparation thereof
Hu et al. Synthesis, characterization and antibacterial activity of guanidinylated chitosan
Feng et al. Preparation, characterization and antibacterial activity of water-soluble O-fumaryl-chitosan
EP2451845B1 (en) Preservatives from chitin derivatives
Affes et al. Preparation of a crude chitosanase from blue crab viscera as well as its application in the production of biologically active chito-oligosaccharides from shrimp shells chitosan
CN105237655B (en) Marine organism polysaccharide Schiff base derivative, preparation method thereof, and application thereof as agricultural bactericide
WO2022165940A1 (en) Chitosan derivative, preparation method therefor and application thereof
Sharma et al. A review on valorization of chitinous waste
JP2615444B2 (en) Partially N-acylated chitooligosaccharide or salt thereof
Chen et al. Preparation of wood ear medicinal mushroom, Auricularia auricula-judae (Agaricomycetes), melanin and its antioxidant properties: evaluation in vitro and in vivo
KR20020037241A (en) Synthesis and characterization of new chitosan derivatives by use of amino acid
CN105566510B (en) A kind of Portugal's oligosaccharides and its preparation method and application
KR20050025395A (en) Synthesis and characterization of new chitosan derivatives
KR100441270B1 (en) The Method for Preparation of Water Soluble Free Amine Chitosan
KR101113729B1 (en) Process for Preparation of Middle Molecular Chitosan Having Antibacterial Activity against Antibiotic Resistance Bacteria and Uses thereof
KR19990064910A (en) Anti-microbial activity of chitin/chitosan oligomers and surfactants derived from chitin/chitosan
E Dawwam et al. A prospective chitosan produced from a biological source: Extraction, Characterization, and Assessment of biological performance
CN107880153A (en) 6 Carboxy Chitosan aromatic series quaternary ammonium salt derivatives and its preparation and application
Moorthy et al. Synthesis of N alkyl chitosan and their impact on biology and physiology of fall armyworm, Spodoptera frugiperda
JPH08333213A (en) Antivirus / bacterial agent
RU2269542C1 (en) Modified chitosan
Bharathi et al. Characterization and applications of pullulan and chitosan produced by fermentation

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20001112

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20050129

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20051108

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20001112

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20061019

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20070427

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20061019

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I